ST. PAUL, Minn., April 23 /PRNewswire/ -- The Prime Therapeutics LLC (Prime) Board of Directors announced today that Timothy Dickman, President and Chief Executive Officer, has left the company to pursue other interests, effective April 23, 2009. Kim Mageau, Sr. Vice President and Chief Operating Officer, will serve as interim President and Chief Executive Officer.
Dickman has been the President and CEO of Prime since 2002. Commenting on behalf of the board of directors, Tim Crilly, Chairman of the Board, said, “We appreciate the contributions Tim has made to the progress of the company and wish him well in his future work.”
Prime Therapeutics LLC is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.7 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and thirdparty administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 11 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.
CONTACT: Sheila Thelemann, Sr. Manager of Public Relations and Marketing
Communications of Prime Therapeutics, +1-612-777-4252,
sthelemann@primetherapeutics.com
Web site: http://www.primetherapeutics.com/
